We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
-12.36%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$12.7B
AUM Growth
-$3.96B
Cap. Flow
-$1.66B
Cap. Flow %
-13.11%
Top 10 Hldgs %
14.02%
Holding
2,200
New
84
Increased
771
Reduced
1,166
Closed
158
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QLYS icon
1351
Qualys
QLYS
$6.35B
$774K 0.01%
6,135
-615
-9% -$80.6K
IRT icon
1352
Independence Realty Trust
IRT
$4.07B
$768K 0.01%
37,055
+10,596
+40% +$255K
MLI icon
1353
Mueller Industries
MLI
$15.2B
$768K 0.01%
57,672
-59,148
-51% -$801K
TY icon
1354
TRI-Continental Corp
TY
$1.9B
$768K 0.01%
29,380
+11,703
+66% +$336K
NUS icon
1355
Nu Skin
NUS
$267M
$767K 0.01%
17,705
-1,966
-10% -$90.2K
VIR icon
1356
Vir Biotechnology
VIR
$1.49B
$766K 0.01%
+30,087
New +$702K
USNA icon
1357
Usana Health Sciences
USNA
$286M
$764K 0.01%
10,555
+1,298
+14% +$96.7K
COO icon
1358
Cooper Companies
COO
$14.5B
$760K 0.01%
9,712
-9,480
-49% -$839K
PTY icon
1359
PIMCO Corporate & Income Opportunity Fund
PTY
$2.51B
$759K 0.01%
60,646
+12,170
+25% +$174K
BC icon
1360
Brunswick
BC
$5.28B
$758K 0.01%
11,587
-8,446
-42% -$621K
CHE icon
1361
Chemed
CHE
$7.22B
$758K 0.01%
1,615
-150
-8% -$73.2K
SYBT icon
1362
Stock Yards Bancorp
SYBT
$2.6B
$757K 0.01%
12,653
-2,182
-15% -$122K
CZR icon
1363
Caesars Entertainment
CZR
$6.14B
$756K 0.01%
19,742
-5,401
-21% -$301K
UTZ icon
1364
Utz Brands
UTZ
$1.25B
$755K 0.01%
54,639
-2,058
-4% -$28.6K
ICVT icon
1365
iShares Convertible Bond ETF
ICVT
$7.35B
$754K 0.01%
10,873
+339
+3% +$25.4K
JHS
1366
John Hancock Income Securities Trust
JHS
$127M
$754K 0.01%
66,229
-10,340
-14% -$128K
ATC
1367
DELISTED
Atotech Limited
ATC
$753K 0.01%
38,899
+10,707
+38% +$221K
HGLB
1368
Highland Global Allocation Fund
HGLB
$177M
$752K 0.01%
77,787
+21,178
+37% +$215K
EDIT icon
1369
Editas Medicine
EDIT
$442M
$750K 0.01%
63,399
+8,739
+16% +$117K
FOXF icon
1370
Fox Factory Holding Corp
FOXF
$886M
$749K 0.01%
9,295
-973
-9% -$81.9K
VNQI icon
1371
Vanguard Global ex-US Real Estate ETF
VNQI
$3.53B
$747K 0.01%
16,880
+910
+6% +$43.5K
DYFN
1372
DELISTED
Angel Oak Dynamic Financial Strategies Income Term Trust
DYFN
$747K 0.01%
43,848
-1,325
-3% -$23.2K
VALE icon
1373
Vale
VALE
$62.6B
$745K 0.01%
50,886
-31,341
-38% -$535K
CVI icon
1374
CVR Energy
CVI
$3.13B
$741K 0.01%
22,108
-4,518
-17% -$144K
SCD
1375
LMP Capital and Income Fund
SCD
$358M
$740K 0.01%
60,058
-1,394
-2% -$18.8K

Similar funds

Guggenheim Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Guggenheim Capital held 2,200 positions worth $12.7B, down 24% from $16.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Guggenheim Capital withdrew a net $1.66B in Q2 2022, closing 158 positions and reducing 1,166 holdings. Its most notable exit was BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC, an estimated $13.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Guggenheim Capital opened a new position in ESAB worth $3.14M.

  • Guggenheim Capital's largest Q2 2022 buy was ESAB: 71,750 shares worth $3.14M.
  • Guggenheim Capital added most to Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in Q2 2022, an estimated $25.1M increase.
  • Guggenheim Capital's biggest Q2 2022 reduction was Apple, cutting an estimated $68.5M.
  • Guggenheim Capital fully exited BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC in Q2 2022, selling an estimated $13.1M.
  • Guggenheim Capital's ten largest holdings make up 14% of its $12.7B portfolio in Q2 2022.
  • Guggenheim Capital opened 84 new positions and closed 158 in Q2 2022.
  • Guggenheim Capital's portfolio value fell 24% quarter-over-quarter to $12.7B.

Based on Guggenheim Capital's 13F filing for Q2 2022, filed 15 Aug 2022.